Global Custom Antibody market

As compared to other antibodies, custom antibodies are easy to produce, therefore they are highly preferred for various types of research studies. The global custom antibody market is being driven by the factors such as rising investment in research and development and new product launches by prominent market players. For instance, in 2018, Abcam launched two custom antibodies, (PBS)-only recombinant antibodies and an anti-PD-L1 antibody clone called MKP1A07310, in collaboration with Merck Group. Furthermore, the development of newly engineered protein is expected to boost the market demand for custom antibodies in the coming years. However, the presence of antibody alternatives may impede market growth over the forecast period of 2020-2027.

The global Custom Antibody market is valued approximately at USD 350.89 Million in 2020 and is anticipated to grow with a healthy growth rate of 11.21% over the forecast period 2020-2027.

Asia Pacific, North America, Europe, Latin America, and the Rest of the World are the regions considered in the regional analysis of the custom antibody market. North America is the leading region across the world in terms of market share due to growing research in the field of proteomics and genomics and increasing investment in structure-based drug designs. Whereas, the Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2020-2027, due to heavy investment in life sciences and genomics research by emerging economies such as India and China.
Major market player included in this report are Thermo Fisher Scientific Inc., Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland immunochemical Inc., Promab Biotechnologies, Inc., Innovagen Ab

The detailed segments and sub-segment of the market are explained below:

By Service: Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling
By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Custom Antibodies
By Source: Mice, Rabbits, Other Sources
By Research Area: Oncology, Infectious Diseases, Immunology, Neurobiology, Stem Cells, Cardiovascular Diseases, Other Research Areas
By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations

By Region:
North America, Europe, Asia Pacific, Latin America, Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2017, 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Custom Antibody Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Review our report at

To review more reports on Upcoming topics, visit us at

Data drives better decisions
Bizwit Research & Consulting LLP